Modulation of the expression of Bcl-2 and related proteins in human leukemia cells by protein kinase C activators: Relationship to effects on 1-[β-D-arabinofuranosyl]cytosine-induced apoptosis

Cell Death and Differentiation

Volumn 4, Issue 4, 1997, Pages 294-303

  Bartimole, Tina M ^a   Vrana, Julie A ^a   Freemerman, Alex J ^a   Jarvis, W David ^a   Reed, John C ^c   Boise, Lawrence H ^b   Grant, Steven ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c BURNHAM INSTITUTE   (United States)

Author keywords

Apoptosis; ara C; bcl 2; Bryostatin 1; Protein kinase C

Indexed keywords

BRYOSTATIN 1; CALCIMYCIN; CELL PROTEIN; CYTARABINE; ENZYME ACTIVATOR; MESSENGER RNA; MEZEREIN; PHORBOL DIBUTYRATE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE C;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL STRAIN HL 60; CONTROLLED STUDY; ETIOLOGY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LEUKEMIA CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 0030921986     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400242     Document Type: Article

References (55)

1. L Blood 87. 3837 - 3843
2. Blagosklonny MV, Alvarez M, Fojo A and Neckers LM (1996a) Bcl-2 protein downregulation is not required for differentiation of multidrug resistant HL-60 leukemia cells. Leukemia Res. 20: 101 -107
3. Blagosklonny MV, Schulte T, Nguyen P, Trepel J and Neckers LM (1996b) Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res. 56:1851 - 1854
4. Bodrug S, Aime-Sempe C, Sato T, Krajewski S, Hanada M and Reed JC (1995) Biochemical and functional comparisons of Mcl-1 and Bcl-2 proteins: evidence for a novel mechanism regulating Bcl-2 family protein function Cell Death Differ. 2: 173-182
5. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G and Thompson CB (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597 - 608
6. L Immunity 3: 87-98
7. Campos L, Roualult J-P, Sabido P, Onol N, Roubi C, Vasselon E, Archimbaud E, Magaud J-P and Guyotat D (1993) High expression of bcl-2 protein in acute myeloidleukemia cells is associated with a poor response to treatment. Blood 81: 3091 -3096
8. ras-generated signals towards cell growth or apoptosis is determined by protein kinase C and Bcl-2 Oncogene 11 : 1487 - 1498
9. Chen M, Quintans J, Fuks Z, Thompson C, Kufe DW and Weichselbaum RR (1995) Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factorα, and ceramide. Cancer Res. 55: 991 - 994
10. Chmura SJ, Nodzenski E, Weichselbaum RR and Quintans J (1996) Protein kinase C inhibition induces apoptosis and ceramide production through activation of a neutral sphingomyelinase. Cancer Res. 56: 2711 - 2714
11. Del Bino G, Li F, Traganos F and Darzynkiewicz Z (1994) Altered susceptibility of differentiating HL-60 cells to apoptosis induced by antitumor drugs. Leukemia 8: 281 - 288
12. Delia D, Aiello A, Soligo D, Fontanella E, Melani C, Pezzela F, Pierotti MA and Della Porta G (1992) bcl2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood 79: 1291 - 1297
13. Drexler HG, Gignac SM, Jones RA, Scott CS, Pettit GR and Hoffbrand AV (1989) Bryostatin 1 induces differentiation of B-chronic lymphocytic leukemia cells. Blood 74: 1747 - 1757
14. Gallagher R, Collins S, Trujillo J, McCredie K, Ahearn M, Tsai S, Metzgar R, Aulakh G, Ting R, Ruscetti F and Gallo R (1979) Characterization of the continuous differentiating cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 54: 713 - 733
15. L and Bcl-2 to prevent apoptosis can be differentially regulated. Cell Death Differ. 3: 113 - 118
16. Grant S, Jarvis D, Swerdlow P, Turner A, Traylor R, Wallace H, Lin P-S, Pettit GR and Gewirtz DA (1992) Potentiation of the activity of 1-β-D-arabinofuranosylcytosine by the macrocyclic lactone PKC activator bryostatin 1 is associated with enhanced fragmentation of mature DNA. Cancer Res. 52: 6270 - 6278
17. Grant S, Rao A, Freemerman AJ, Turner A, Komstein M, Cehlliah J and Jarvis WD (1995) Divergent effects of calcium ionophore (A23187) on bryostatin 1-related differentiation induction and apoptosis in human promyelocytic leukemia cells (HL-60). Mol. Cell Differentiation 3: 337 - 359
18. Haldar S, Chintapalli J and Croce CM (1995a) Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res. 56: 1253 - 1255
19. Haldar S, Jena N and Croce CM (1995b) Inactivation of Bcl-2 by phosphorylation. Proc. Natl Acad Sci. USA 92. 4507 - 4511
20. Hu Z-B, Minden MD and McCulloch EA (1996) Post-transcriptional regulation of bcl-2 in acute myeloid leukemia: significance for response to chemotherapy. Leukemia 10: 410 - 416
21. Isakov N, Galron D, Mustelin T, Pettit GR and Altman A (1993) Inhibition of phorbol ester-induced T cell proliferation by bryostatin 1 is associated with rapid degradation of protein kinase C. J. Immunol. 150: 1195 - 1204
22. Jarvis WD, Foman F, Kolesnick RN, Browning JL, Gewirtz DA and Grant S (1994a) Attenuation of ceramide-induced apoptosis in human promyelocytic leukemia cells by diglycende. J. Biol. Chem. 269: 31685 - 31692
23. Jarvis WD, Gewirtz DA, Povirk L, Turner A, Traylor R, Pettit GR and Grant S (1994b) Effect of bryostatin 1 and other activators of protein kinase C on 1-β-D-arabinofuranosylcytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells. Biochem. Pharmacol. 47: 839 - 852
24. Jarvis WD, Povirk L, Turner A, Traylor R and Grant S (1994c) Induction of DNA fragmentation and cell death in (HL-60) human promyelocytic leukemia cells by pharmacologic inhibitors of protein kinase C. Cancer Res 54. 1707 - 1714
25. Kaufmann SH (1989) Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res 49: 5870 - 5878
26. Kitada S, Takayama S, De Riel K, Tanaka S and Reed JC (1994) Reversal of chemoresistance of lymphoma cells by antisense-mediated reduction of bcl-2 gene expresion. Antisense Res. Dev. 4: 71 - 79
27. Kozopas KM, Yang T, Buchan HL, Zhou P and Craig R (1993) Mcl-1, a gene expressed in programmed cell death, has sequence similarity to bcl-2. Proc. Natl. Acad. Sci. USA 90: 3516 - 3520
28. Kraft AS, Smith JB and Berkow RL (1986) Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60. Proc Natl. Acad. Sci. USA 83: 1334 - 1338
29. Kraft AS, William F, Pettit GR and Lilly MB (1989) Varied differentiation responses of human leukemias to bryostatin 1. Cancer Res. 49: 1287 - 1293
30. Krajewski S, Bodrug S, Gascoyne R, Berean K, Krajewska M and Reed JC (1994a) Immunohistochemical analysis of mcl-1 and bcl-2 proteins in normal and neoplastic lymph nodes. Am. J. Pathol. 145. 515 - 525
31. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang H-G and Reed JC (1994b) Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of bcl-2 Am. J. Pathol. 145: 1323 - 1333
32. Kucera GL and Capizzi RL (1992) 1-β-D-arabinofuranosylcytosine diphosphate-choline is formed by the reversal of cholinephosphotransferase and not by cytidlylytransferase Cancer Res. 52: 3886 - 3891
33. Lin EY, Orlofsky A, Wang A-G, Reed JC and Prystowsky MB (1996) A1, a Bcl-2 family member, prolongs cell survival and permits myeloid differentiation. Blood 87. 983 - 992
34. Lomo J, Smeiand EB, Krajewski S, Reed JC and Biomhoff HK (1996) Expression of the Bcl-2 homolog Mcl-1 correlates with survival of peripheral blood B lymphocytes. Cancer Res. 56: 40 - 43
35. L, and bax in the control of apoptosis by hematopoietic cytokines and dexamethasone. Cell Growth Diff. 6: 647 - 653
36. Maki A, Diwakaran H, Redman B, Al-Asfar S, Pettit GR, Mohammad RM and Al-Katib A (1995) The bcl-2 and p53 oncoproteins can be modulated by bryostatin 1 and dolastatins in human large cell lymphoma. Anti-Cancer Drugs 6: 392 - 397
37. Martin SJ, Bradley JG and Cotter TG (1990) HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin Exp. Immunol. 79: 448-453
38. Martin SJ, Takayama S, McGahon AJ, Miyashita T, Corbell J, Kolesnick RN, Reed JC and Green DR (1995) Inhibition of ceramide-induced apoptosis by Bcl-2. Cell Death Differ. 2: 253 - 258
39. May WS, Tyler PG, Ito T, Armstrong DK, Qatsha KA and Davidson NE (1994) Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of Bcl2α in association with suppression of apoptosis. J. Biol. Chem. 43: 26865 - 26870
40. L can confer a multidrug-resistance phenotype. Blood 86: 1903 - 1910
41. Miyashita T and Reed JC (1993) Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line Blood 81: 151 - 157
42. Naumovski L and Cleary ML (1994) Bcl2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cells. Blood 83: 2261 - 2267
43. Ohta H, Sweeney EA, Masamune A, Yatomi Y, Hakomon S and Igarashi Y (1995) Induction of apoptosis by sphingosine in human leukemic HL-60 cells: a possible endogenous modulator of apoptotic DNA fragmentation occurring during phorbol ester-induced differentiation. Cancer Res 55: 691 - 697
44. Oltavi ZN and Korsmeyer SJ (1994) Checkpoints of dueling dimers foil death wishes. Cell 79: 189 - 192
45. Oltavi Z, Milliman C and Korsmeyer SJ (1993) Bcl-2 heterodimenzes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609 - 619
46. Park JR, Robertson K, Hickstein DD, Schickwann T, Hockenbery DM and Collins SJ (1994) Dys regulated bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid-induced HL-60 granulocytes. Blood 84: 440 - 445
47. Reed JC (1994) Bcl-2 and the regulation of programmed cell death. J. Cell Biol 124: 1 - 6
48. Reynolds JE, Yang T, Qian L, Jenkinson JD, Zhou P, Eastman A and Craig RW (1994) Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells. Cancer Res. 54: 6348 - 6352
49. Rinaudo MS, Su K, Falk LA, Haldar S and Mufson RA (1995) Human interleukin-3 receptor modulates bcl-2 mRNA and protein levels through protein kinase C in TF-1 cells. Blood 86 80 - 88
50. Solary E, Bertrand R, Kohn K and Pommier Y (1993) Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors. Blood 81: 1359 - 1368
51. Stone RM, Sariban E, Pettit GR and Kufe DW (1988) Bryostatin 1 activates protein kinase C and induces monocytic differentiation of HL-60 cells. Blood 72: 208 - 213
52. Strum JC, Small GW, Pauig SB and Daniel LW (1994) 1-β-D-arabinofuranosylcytosine stimulates ceramide and diglycende formation in HL-60 cells. J. Biol Chem. 269: 15493 - 15497
53. Xu H-M, Tepper CG, Jones JB, Fernandez CE and Studzinski GP (1993) 1,25 dihydroxyvitamin Dprotects HL-60 cells against apoptosis but down-regulates the expression of the bcl-2 gene. Ex. Cell Res. 209: 367 - 374
54. L and Bcl-2, displaces bax and promotes cell death Cell 80: 285 - 291
55. Yunis JJ, Mayer MG, Arensen MA, Aeppli DP, Oken MM and Frizzera G (1989) Bcl-2 and other genomic alterations in the prognosis of large cell lymphomas. N. Engl. J. Med. 320: 1047 - 1054